 | • レポートコード：QYR2104Z3679 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、95ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療 |
| Single User | ￥565,500 (USD3,900) | ▷ お問い合わせ |
| Multi User/Five User | ￥848,250 (USD5,850) | ▷ お問い合わせ |
| Enterprise License（同一法人内共有可） | ￥1,131,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査資料では、黒色腫がんのグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（非浸潤性黒色腫、浸潤性黒色腫）、用途別市場規模（病院、がん研究センター）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・黒色腫がんの市場動向 ・企業の競争状況、市場シェア ・黒色腫がんの種類別市場規模（非浸潤性黒色腫、浸潤性黒色腫） ・黒色腫がんの用途別市場規模（病院、がん研究センター） ・黒色腫がんの北米市場規模2016-2027（アメリカ、カナダ） ・黒色腫がんのヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・黒色腫がんのアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・黒色腫がんの中南米市場規模2016-2027（メキシコ、ブラジル） ・黒色腫がんの中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（AB Sciences、Incyte、Merck、Novartis、Pierre Fabre、Amgen、AstraZeneca、Bristol-Myers Squibb、Daiichi Sankyo） ・結論 |
Market Analysis and Insights: Global Melanoma Cancer Market
The global Melanoma Cancer market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Melanoma Cancer market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Melanoma Cancer market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Melanoma Cancer market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Melanoma Cancer market.
Global Melanoma Cancer Scope and Market Size
Melanoma Cancer market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Melanoma Cancer market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Non-invasive melanoma
Invasive melanoma
Segment by Application
Hospitals
Cancer Research Centers
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
AB Sciences
Incyte
Merck
Novartis
Pierre Fabre
Amgen
AstraZeneca
Bristol-Myers Squibb
Daiichi Sankyo
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Melanoma Cancer Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Non-invasive melanoma
1.2.3 Invasive melanoma
1.3 Market by Application
1.3.1 Global Melanoma Cancer Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospitals
1.3.3 Cancer Research Centers
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Melanoma Cancer Market Perspective (2016-2027)
2.2 Melanoma Cancer Growth Trends by Regions
2.2.1 Melanoma Cancer Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Melanoma Cancer Historic Market Share by Regions (2016-2021)
2.2.3 Melanoma Cancer Forecasted Market Size by Regions (2022-2027)
2.3 Melanoma Cancer Industry Dynamic
2.3.1 Melanoma Cancer Market Trends
2.3.2 Melanoma Cancer Market Drivers
2.3.3 Melanoma Cancer Market Challenges
2.3.4 Melanoma Cancer Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Melanoma Cancer Players by Revenue
3.1.1 Global Top Melanoma Cancer Players by Revenue (2016-2021)
3.1.2 Global Melanoma Cancer Revenue Market Share by Players (2016-2021)
3.2 Global Melanoma Cancer Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Melanoma Cancer Revenue
3.4 Global Melanoma Cancer Market Concentration Ratio
3.4.1 Global Melanoma Cancer Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Melanoma Cancer Revenue in 2020
3.5 Melanoma Cancer Key Players Head office and Area Served
3.6 Key Players Melanoma Cancer Product Solution and Service
3.7 Date of Enter into Melanoma Cancer Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Melanoma Cancer Breakdown Data by Type
4.1 Global Melanoma Cancer Historic Market Size by Type (2016-2021)
4.2 Global Melanoma Cancer Forecasted Market Size by Type (2022-2027)
5 Melanoma Cancer Breakdown Data by Application
5.1 Global Melanoma Cancer Historic Market Size by Application (2016-2021)
5.2 Global Melanoma Cancer Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Melanoma Cancer Market Size (2016-2027)
6.2 North America Melanoma Cancer Market Size by Type
6.2.1 North America Melanoma Cancer Market Size by Type (2016-2021)
6.2.2 North America Melanoma Cancer Market Size by Type (2022-2027)
6.2.3 North America Melanoma Cancer Market Size by Type (2016-2027)
6.3 North America Melanoma Cancer Market Size by Application
6.3.1 North America Melanoma Cancer Market Size by Application (2016-2021)
6.3.2 North America Melanoma Cancer Market Size by Application (2022-2027)
6.3.3 North America Melanoma Cancer Market Size by Application (2016-2027)
6.4 North America Melanoma Cancer Market Size by Country
6.4.1 North America Melanoma Cancer Market Size by Country (2016-2021)
6.4.2 North America Melanoma Cancer Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada
7 Europe
7.1 Europe Melanoma Cancer Market Size (2016-2027)
7.2 Europe Melanoma Cancer Market Size by Type
7.2.1 Europe Melanoma Cancer Market Size by Type (2016-2021)
7.2.2 Europe Melanoma Cancer Market Size by Type (2022-2027)
7.2.3 Europe Melanoma Cancer Market Size by Type (2016-2027)
7.3 Europe Melanoma Cancer Market Size by Application
7.3.1 Europe Melanoma Cancer Market Size by Application (2016-2021)
7.3.2 Europe Melanoma Cancer Market Size by Application (2022-2027)
7.3.3 Europe Melanoma Cancer Market Size by Application (2016-2027)
7.4 Europe Melanoma Cancer Market Size by Country
7.4.1 Europe Melanoma Cancer Market Size by Country (2016-2021)
7.4.2 Europe Melanoma Cancer Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Melanoma Cancer Market Size (2016-2027)
8.2 Asia-Pacific Melanoma Cancer Market Size by Type
8.2.1 Asia-Pacific Melanoma Cancer Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Melanoma Cancer Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Melanoma Cancer Market Size by Type (2016-2027)
8.3 Asia-Pacific Melanoma Cancer Market Size by Application
8.3.1 Asia-Pacific Melanoma Cancer Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Melanoma Cancer Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Melanoma Cancer Market Size by Application (2016-2027)
8.4 Asia-Pacific Melanoma Cancer Market Size by Region
8.4.1 Asia-Pacific Melanoma Cancer Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Melanoma Cancer Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Melanoma Cancer Market Size (2016-2027)
9.2 Latin America Melanoma Cancer Market Size by Type
9.2.1 Latin America Melanoma Cancer Market Size by Type (2016-2021)
9.2.2 Latin America Melanoma Cancer Market Size by Type (2022-2027)
9.2.3 Latin America Melanoma Cancer Market Size by Type (2016-2027)
9.3 Latin America Melanoma Cancer Market Size by Application
9.3.1 Latin America Melanoma Cancer Market Size by Application (2016-2021)
9.3.2 Latin America Melanoma Cancer Market Size by Application (2022-2027)
9.3.3 Latin America Melanoma Cancer Market Size by Application (2016-2027)
9.4 Latin America Melanoma Cancer Market Size by Country
9.4.1 Latin America Melanoma Cancer Market Size by Country (2016-2021)
9.4.2 Latin America Melanoma Cancer Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Melanoma Cancer Market Size (2016-2027)
10.2 Middle East & Africa Melanoma Cancer Market Size by Type
10.2.1 Middle East & Africa Melanoma Cancer Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Melanoma Cancer Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Melanoma Cancer Market Size by Type (2016-2027)
10.3 Middle East & Africa Melanoma Cancer Market Size by Application
10.3.1 Middle East & Africa Melanoma Cancer Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Melanoma Cancer Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Melanoma Cancer Market Size by Application (2016-2027)
10.4 Middle East & Africa Melanoma Cancer Market Size by Country
10.4.1 Middle East & Africa Melanoma Cancer Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Melanoma Cancer Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 AB Sciences
11.1.1 AB Sciences Company Details
11.1.2 AB Sciences Business Overview
11.1.3 AB Sciences Melanoma Cancer Introduction
11.1.4 AB Sciences Revenue in Melanoma Cancer Business (2016-2021)
11.1.5 AB Sciences Recent Development
11.2 Incyte
11.2.1 Incyte Company Details
11.2.2 Incyte Business Overview
11.2.3 Incyte Melanoma Cancer Introduction
11.2.4 Incyte Revenue in Melanoma Cancer Business (2016-2021)
11.2.5 Incyte Recent Development
11.3 Merck
11.3.1 Merck Company Details
11.3.2 Merck Business Overview
11.3.3 Merck Melanoma Cancer Introduction
11.3.4 Merck Revenue in Melanoma Cancer Business (2016-2021)
11.3.5 Merck Recent Development
11.4 Novartis
11.4.1 Novartis Company Details
11.4.2 Novartis Business Overview
11.4.3 Novartis Melanoma Cancer Introduction
11.4.4 Novartis Revenue in Melanoma Cancer Business (2016-2021)
11.4.5 Novartis Recent Development
11.5 Pierre Fabre
11.5.1 Pierre Fabre Company Details
11.5.2 Pierre Fabre Business Overview
11.5.3 Pierre Fabre Melanoma Cancer Introduction
11.5.4 Pierre Fabre Revenue in Melanoma Cancer Business (2016-2021)
11.5.5 Pierre Fabre Recent Development
11.6 Amgen
11.6.1 Amgen Company Details
11.6.2 Amgen Business Overview
11.6.3 Amgen Melanoma Cancer Introduction
11.6.4 Amgen Revenue in Melanoma Cancer Business (2016-2021)
11.6.5 Amgen Recent Development
11.7 AstraZeneca
11.7.1 AstraZeneca Company Details
11.7.2 AstraZeneca Business Overview
11.7.3 AstraZeneca Melanoma Cancer Introduction
11.7.4 AstraZeneca Revenue in Melanoma Cancer Business (2016-2021)
11.7.5 AstraZeneca Recent Development
11.8 Bristol-Myers Squibb
11.8.1 Bristol-Myers Squibb Company Details
11.8.2 Bristol-Myers Squibb Business Overview
11.8.3 Bristol-Myers Squibb Melanoma Cancer Introduction
11.8.4 Bristol-Myers Squibb Revenue in Melanoma Cancer Business (2016-2021)
11.8.5 Bristol-Myers Squibb Recent Development
11.9 Daiichi Sankyo
11.9.1 Daiichi Sankyo Company Details
11.9.2 Daiichi Sankyo Business Overview
11.9.3 Daiichi Sankyo Melanoma Cancer Introduction
11.9.4 Daiichi Sankyo Revenue in Melanoma Cancer Business (2016-2021)
11.9.5 Daiichi Sankyo Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Melanoma Cancer Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Non-invasive melanoma
Table 3. Key Players of Invasive melanoma
Table 4. Global Melanoma Cancer Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 5. Global Melanoma Cancer Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Melanoma Cancer Market Size by Regions (2016-2021) & (US$ Million)
Table 7. Global Melanoma Cancer Market Share by Regions (2016-2021)
Table 8. Global Melanoma Cancer Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 9. Global Melanoma Cancer Market Share by Regions (2022-2027)
Table 10. Melanoma Cancer Market Trends
Table 11. Melanoma Cancer Market Drivers
Table 12. Melanoma Cancer Market Challenges
Table 13. Melanoma Cancer Market Restraints
Table 14. Global Melanoma Cancer Revenue by Players (2016-2021) & (US$ Million)
Table 15. Global Melanoma Cancer Market Share by Players (2016-2021)
Table 16. Global Top Melanoma Cancer Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Melanoma Cancer as of 2020)
Table 17. Ranking of Global Top Melanoma Cancer Companies by Revenue (US$ Million) in 2020
Table 18. Global 5 Largest Players Market Share by Melanoma Cancer Revenue (CR5 and HHI) & (2016-2021)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Melanoma Cancer Product Solution and Service
Table 21. Date of Enter into Melanoma Cancer Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Melanoma Cancer Market Size by Type (2016-2021) (US$ Million)
Table 24. Global Melanoma Cancer Revenue Market Share by Type (2016-2021)
Table 25. Global Melanoma Cancer Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 26. Global Melanoma Cancer Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 27. Global Melanoma Cancer Market Size Share by Application (2016-2021) & (US$ Million)
Table 28. Global Melanoma Cancer Revenue Market Share by Application (2016-2021)
Table 29. Global Melanoma Cancer Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 30. Global Melanoma Cancer Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 31. North America Melanoma Cancer Market Size by Type (2016-2021) (US$ Million)
Table 32. North America Melanoma Cancer Market Size by Type (2022-2027) & (US$ Million)
Table 33. North America Melanoma Cancer Market Size by Application (2016-2021) (US$ Million)
Table 34. North America Melanoma Cancer Market Size by Application (2022-2027) & (US$ Million)
Table 35. North America Melanoma Cancer Market Size by Country (2016-2021) & (US$ Million)
Table 36. North America Melanoma Cancer Market Size by Country (2022-2027) & (US$ Million)
Table 37. Europe Melanoma Cancer Market Size by Type (2016-2021) (US$ Million)
Table 38. Europe Melanoma Cancer Market Size by Type (2022-2027) & (US$ Million)
Table 39. Europe Melanoma Cancer Market Size by Application (2016-2021) (US$ Million)
Table 40. Europe Melanoma Cancer Market Size by Application (2022-2027) & (US$ Million)
Table 41. Europe Melanoma Cancer Market Size by Country (2016-2021) & (US$ Million)
Table 42. Europe Melanoma Cancer Market Size by Country (2022-2027) & (US$ Million)
Table 43. Asia-Pacific Melanoma Cancer Market Size by Type (2016-2021) (US$ Million)
Table 44. Asia-Pacific Melanoma Cancer Market Size by Type (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Melanoma Cancer Market Size by Application (2016-2021) (US$ Million)
Table 46. Asia-Pacific Melanoma Cancer Market Size by Application (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Melanoma Cancer Market Size by Region (2016-2021) & (US$ Million)
Table 48. Asia-Pacific Melanoma Cancer Market Size by Region (2022-2027) & (US$ Million)
Table 49. Latin America Melanoma Cancer Market Size by Type (2016-2021) (US$ Million)
Table 50. Latin America Melanoma Cancer Market Size by Type (2022-2027) & (US$ Million)
Table 51. Latin America Melanoma Cancer Market Size by Application (2016-2021) (US$ Million)
Table 52. Latin America Melanoma Cancer Market Size by Application (2022-2027) & (US$ Million)
Table 53. Latin America Melanoma Cancer Market Size by Country (2016-2021) & (US$ Million)
Table 54. Latin America Melanoma Cancer Market Size by Country (2022-2027) & (US$ Million)
Table 55. Middle East & Africa Melanoma Cancer Market Size by Type (2016-2021) (US$ Million)
Table 56. Middle East & Africa Melanoma Cancer Market Size by Type (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Melanoma Cancer Market Size by Application (2016-2021) (US$ Million)
Table 58. Middle East & Africa Melanoma Cancer Market Size by Application (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Melanoma Cancer Market Size by Country (2016-2021) & (US$ Million)
Table 60. Middle East & Africa Melanoma Cancer Market Size by Country (2022-2027) & (US$ Million)
Table 61. AB Sciences Company Details
Table 62. AB Sciences Business Overview
Table 63. AB Sciences Melanoma Cancer Product
Table 64. AB Sciences Revenue in Melanoma Cancer Business (2016-2021) & (US$ Million)
Table 65. AB Sciences Recent Development
Table 66. Incyte Company Details
Table 67. Incyte Business Overview
Table 68. Incyte Melanoma Cancer Product
Table 69. Incyte Revenue in Melanoma Cancer Business (2016-2021) & (US$ Million)
Table 70. Incyte Recent Development
Table 71. Merck Company Details
Table 72. Merck Business Overview
Table 73. Merck Melanoma Cancer Product
Table 74. Merck Revenue in Melanoma Cancer Business (2016-2021) & (US$ Million)
Table 75. Merck Recent Development
Table 76. Novartis Company Details
Table 77. Novartis Business Overview
Table 78. Novartis Melanoma Cancer Product
Table 79. Novartis Revenue in Melanoma Cancer Business (2016-2021) & (US$ Million)
Table 80. Novartis Recent Development
Table 81. Pierre Fabre Company Details
Table 82. Pierre Fabre Business Overview
Table 83. Pierre Fabre Melanoma Cancer Product
Table 84. Pierre Fabre Revenue in Melanoma Cancer Business (2016-2021) & (US$ Million)
Table 85. Pierre Fabre Recent Development
Table 86. Amgen Company Details
Table 87. Amgen Business Overview
Table 88. Amgen Melanoma Cancer Product
Table 89. Amgen Revenue in Melanoma Cancer Business (2016-2021) & (US$ Million)
Table 90. Amgen Recent Development
Table 91. AstraZeneca Company Details
Table 92. AstraZeneca Business Overview
Table 93. AstraZeneca Melanoma Cancer Product
Table 94. AstraZeneca Revenue in Melanoma Cancer Business (2016-2021) & (US$ Million)
Table 95. AstraZeneca Recent Development
Table 96. Bristol-Myers Squibb Company Details
Table 97. Bristol-Myers Squibb Business Overview
Table 98. Bristol-Myers Squibb Revenue in Melanoma Cancer Business (2016-2021) & (US$ Million)
Table 99. Bristol-Myers Squibb Recent Development
Table 100. Daiichi Sankyo Company Details
Table 101. Daiichi Sankyo Business Overview
Table 102. Daiichi Sankyo Melanoma Cancer Product
Table 103. Daiichi Sankyo Revenue in Melanoma Cancer Business (2016-2021) & (US$ Million)
Table 104. Daiichi Sankyo Recent Development
Table 105. Research Programs/Design for This Report
Table 106. Key Data Information from Secondary Sources
Table 107. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Melanoma Cancer Market Share by Type: 2020 VS 2027
Figure 2. Non-invasive melanoma Features
Figure 3. Invasive melanoma Features
Figure 4. Global Melanoma Cancer Market Share by Application: 2020 VS 2027
Figure 5. Hospitals Case Studies
Figure 6. Cancer Research Centers Case Studies
Figure 7. Melanoma Cancer Report Years Considered
Figure 8. Global Melanoma Cancer Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 9. Global Melanoma Cancer Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 10. Global Melanoma Cancer Market Share by Regions: 2020 VS 2027
Figure 11. Global Melanoma Cancer Market Share by Regions (2022-2027)
Figure 12. Global Melanoma Cancer Market Share by Players in 2020
Figure 13. Global Top Melanoma Cancer Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Melanoma Cancer as of 2020
Figure 14. The Top 10 and 5 Players Market Share by Melanoma Cancer Revenue in 2020
Figure 15. Global Melanoma Cancer Revenue Market Share by Type (2016-2021)
Figure 16. Global Melanoma Cancer Revenue Market Share by Type (2022-2027)
Figure 17. North America Melanoma Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 18. North America Melanoma Cancer Market Share by Type (2016-2027)
Figure 19. North America Melanoma Cancer Market Share by Application (2016-2027)
Figure 20. North America Melanoma Cancer Market Share by Country (2016-2027)
Figure 21. United States Melanoma Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 22. Canada Melanoma Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. Europe Melanoma Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Europe Melanoma Cancer Market Share by Type (2016-2027)
Figure 25. Europe Melanoma Cancer Market Share by Application (2016-2027)
Figure 26. Europe Melanoma Cancer Market Share by Country (2016-2027)
Figure 27. Germany Melanoma Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. France Melanoma Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. U.K. Melanoma Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. Italy Melanoma Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. Russia Melanoma Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Nordic Melanoma Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Asia-Pacific Melanoma Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Asia-Pacific Melanoma Cancer Market Share by Type (2016-2027)
Figure 35. Asia-Pacific Melanoma Cancer Market Share by Application (2016-2027)
Figure 36. Asia-Pacific Melanoma Cancer Market Share by Region (2016-2027)
Figure 37. China Melanoma Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Japan Melanoma Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. South Korea Melanoma Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Southeast Asia Melanoma Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. India Melanoma Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Australia Melanoma Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Latin America Melanoma Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Latin America Melanoma Cancer Market Share by Type (2016-2027)
Figure 45. Latin America Melanoma Cancer Market Share by Application (2016-2027)
Figure 46. Latin America Melanoma Cancer Market Share by Country (2016-2027)
Figure 47. Mexico Melanoma Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Brazil Melanoma Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Middle East & Africa Melanoma Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Middle East & Africa Melanoma Cancer Market Share by Type (2016-2027)
Figure 51. Middle East & Africa Melanoma Cancer Market Share by Application (2016-2027)
Figure 52. Middle East & Africa Melanoma Cancer Market Share by Country (2016-2027)
Figure 53. Turkey Melanoma Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Saudi Arabia Melanoma Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. UAE Melanoma Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. AB Sciences Revenue Growth Rate in Melanoma Cancer Business (2016-2021)
Figure 57. Incyte Revenue Growth Rate in Melanoma Cancer Business (2016-2021)
Figure 58. Merck Revenue Growth Rate in Melanoma Cancer Business (2016-2021)
Figure 59. Novartis Revenue Growth Rate in Melanoma Cancer Business (2016-2021)
Figure 60. Pierre Fabre Revenue Growth Rate in Melanoma Cancer Business (2016-2021)
Figure 61. Amgen Revenue Growth Rate in Melanoma Cancer Business (2016-2021)
Figure 62. AstraZeneca Revenue Growth Rate in Melanoma Cancer Business (2016-2021)
Figure 63. Bristol-Myers Squibb Revenue Growth Rate in Melanoma Cancer Business (2016-2021)
Figure 64. Daiichi Sankyo Revenue Growth Rate in Melanoma Cancer Business (2016-2021)
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed
世界の黒色腫がん診断市場規模・現状・予測（2021年-2027年） Melanoma is a type of skin cancer developing from pigment-containing cells known as melanocytes. Melanoma cancer diagnostics is to diagnose melanoma with biopsy. During a biopsy, all or the part of mole or growth over the skin is removed to test and analyze the sample. Common biopsy procedures used …- 世界の非黒色腫皮膚がん市場規模・現状・予測（2021年-2027年） Non-melanoma skin cancer is usually treated as a simple lesion in the initial stages but if not treated properly, it can quickly mushroom and spread to other body parts. Radiation therapy has a market share approaching 88% in the non-melanoma skin cancer treatment market in 2017 itself and is unlike…
- 世界の非黒色腫皮膚がん治療市場規模・現状・予測（2021年-2027年） Non-melanoma skin cancer is usually treated as a simple lesion in the initial stages but if not treated properly, it can quickly mushroom and spread to other body parts. Radiation therapy has a market share approaching 88% in the non-melanoma skin cancer treatment market in 2017 itself and is unlike…
- 世界の末端黒子型黒色腫治療市場規模・現状・予測（2021年-2027年） Acral Lentiginous Melanoma Drugs, a lymphokine, is produced by recombinant DNA technology using a genetically engineered E. coli strain containing an analog of the human interleukin-2 gene. Market Analysis and Insights: Global Acral Lentiginous Melanoma Treatment Market The global Acral Lentiginous …
- 世界の黒色腫市場規模・現状・予測（2021年-2027年） Melanoma, also known as malignant melanoma, is a type of cancer that develops from the pigment-containing cells known as melanocytes. Melanomas typically occur in the skin, but may rarely occur in the mouth, intestines, or eye. In women, they most commonly occur on the legs, while in men they are mo…